{"disease":{"id":"poly-adp-ribose-polymerase-parp-inhibitor","name":"poly adp ribose polymerase parp inhibitor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04740190","title":"Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"The University of Hong Kong","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}